Gabinet Dermatlogiczny. Beata Krecisz

Kielce, Świętokrzyskie Voivodeship 25-155

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. — Completed